Condition

ARDS (4)

Covid19 (2)

Acute Hypoxemic Respiratory Failure (1)

Acute Respiratory Distress Syndrome (1)

Endothelial Dysfunction (1)

Pulmonary Edema (1)

Ultrasound (1)

Overall Status

Recruiting (3)

Terminated (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)

Dr. Jurjan Aman (1)

Unity Health Toronto (1)

Collaborator

Centre Hospitalier Universitaire de Brussels, Brussels, Belgium (1)

Exvastat Ltd. (1)

Hamilton Medical AG (1)

KABS laboratories (1)

Miulli Regional Hospital, Acquaviva delle Fonti, Italy (1)

Simbec-Orion Group (1)

University of Bari Aldo Moro (1)

University of Foggia (1)

Intervention

conventional lung protective ventilation (1)

imatinib mesylate intravenous solution (1)

intellivent-asv (1)

placebo (1)

Study Documents

Intervention Type

device (1)

drug (1)

other (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (1)

Observational [Patient Registry] (1)

ARDS

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

ARDS, Acute Hypoxemic Respiratory Failure Trial in Worldwide

Recruiting

ARDS
Acute Hypoxemic Respiratory Failure

Toronto, Ontario, Canada
+13 more

Sep 29, 2021

ARDS, Acute Respiratory Distress Syndrome, Covid19 Trial in Amsterdam (Imatinib Mesylate intravenous solution, Placebo)

Recruiting

ARDS
+4 more

Imatinib Mesylate intravenous solution
Placebo

Amsterdam, Noord-Holland, Netherlands
+1 more

Mar 23, 2021

Lung Ultrasound in COVID-19 Patients

Recruiting

Covid19
+2 more

Amsterdam, Netherlands

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA

Jan 18, 2021

ARDS Trial in Amsterdam (INTELLiVENT-ASV, Conventional lung protective ventilation)

Terminated

ARDS

INTELLiVENT-ASV
Conventional lung protective ventilation

Amsterdam, Netherlands

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA

Mar 4, 2019